However, the minimal levels of PfMSP1-19 specific growth inhibitory activity seen in the study population, and the lack of any association between MSP1-19 specific inhibitory antibodies and active parasitemia at enrolment, suggests that subsequent parasite reinfection is unlikely to increase PfMSP1-19 inhibitory activity. The gene discussed is ATAD1; the disease is parasitic infectious disease.